Amid the COVID-19 crisis and the looming economic recession, the Clinical Trial Management Systems (CTMS) market worldwide will grow by a projected US$875.4 Million, during the analysis period

New York, May 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Clinical Trial Management Systems (CTMS) Industry" - https://www.reportlinker.com/p05336779/?utm_source=GNW
1 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Enterprise CTMS market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 13.3% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$32.4 Million to the region’s size over the next 7 to 8 years. In addition, over US$39.5 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Enterprise CTMS segment will reach a market size of US$66.3 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Clinical Trial Management Systems (CTMS) market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 12.2% over the next couple of years and add approximately US$127.2 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Clinical Trial Management Systems (CTMS) market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, ArisGlobal LLC; BioClinica Inc.; Bio-Optronics Inc.; DSG Inc.; eResearch Technology Inc.; IBM Watson Health; Medidata Solutions; MedNet Solutions; Nextrials Inc.; Oracle Corp.; PAREXEL International Corp.; Trial By Fire Solutions LLC; Veeva Systems Inc.


Read the full report: https://www.reportlinker.com/p05336779/?utm_source=GNW

CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MCP-6
MARKET ANALYSIS, TRENDS, AND FORECASTS, JUNE 2
CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Clinical Trial Management Systems (CTMS) Gain Ground Recent Market Activity Benefits Offered by CTMS Global Market Overview Clinical Trial Management Systems Market to Post Explosive Growth Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth Key Players in the CTMS Market Developed Countries Rule the Market Pharmaceutical Firms and CROs to Drive Adoption Rate Noteworthy Transformations in the Global Clinical Trial Sector Global Competitor Market Shares Clinical Trial Management Systems (CTMS) Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
ArisGlobal, LLC (USA) BioClinica, Inc. (USA) Bio-Optronics, Inc. (USA) DSG, Inc. (USA) eResearch Technology, Inc. (USA) IBM Watson Health (USA) MedNet Solutions (USA) Medidata Solutions (USA) Nextrials, Inc. (USA) Oracle Corp. (USA) PAREXEL International Corp. (USA) Trial By Fire Solutions, LLC (USA) Veeva Systems, Inc. (USA) Winchester Business Systems (USA)
3. MARKET TRENDS & DRIVERS
Surging Global Population Offers Increased Growth Opportunities Increased Spend on R&D - An Important Growth Driver CROs - The Targeted Customers for CTMS Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand CROs Adept with New Technologies to See More Business in Future Rise in Clinical Trial Complexities Propels CTMS Demand Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand Adoption of Digital Technologies Gains Pace Clinical Trial Operators Demand Efficient Data Management Platforms DLB System’s Solution with Data Management Tools Systems Integration Becomes Imperative Technological Innovations Drive Market Growth MC10 Introduces BioStampRC System to Capture Clinical Trial Data UF Health Cancer Center Unveils OnCore® Clinical Trials Management System UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution
4. GLOBAL MARKET PERSPECTIVE
Table 1: Clinical Trial Management Systems (CTMS) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 2: Clinical Trial Management Systems (CTMS) Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 Table 3: Clinical Trial Management Systems (CTMS) Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Enterprise CTMS (Type) World Market by Region/Country in US$ Thousand: 2020 to 2027 Table 5: Enterprise CTMS (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 Table 6: Enterprise CTMS (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Site CTMS (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 Table 8: Site CTMS (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019 Table 9: Site CTMS (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 Table 10: Web-based (Hosted) (Delivery Mode) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 Table 11: Web-based (Hosted) (Delivery Mode) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019 Table 12: Web-based (Hosted) (Delivery Mode) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 Table 13: Licensed Enterprise (On-Premise) (Delivery Mode) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027 Table 14: Licensed Enterprise (On-Premise) (Delivery Mode) Market Historic Review by Region/Country in US$ Thousand: 2
to 2019 Table 15: Licensed Enterprise (On-Premise) (Delivery Mode) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 Table 16: Cloud-based (SaaS) (Delivery Mode) World Market by Region/Country in US$ Thousand: 2020 to 2027 Table 17: Cloud-based (SaaS) (Delivery Mode) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 Table 18: Cloud-based (SaaS) (Delivery Mode) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 Table 19: Pharmaceutical & Biopharmaceutical (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027 Table 20: Pharmaceutical & Biopharmaceutical (End-Use) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to 2019 Table 21: Pharmaceutical & Biopharmaceutical (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 Table 22: Contract Research Organizations (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027 Table 23: Contract Research Organizations (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019 Table 24: Contract Research Organizations (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2
VS 2027 Table 25: Medical Devices (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027 Table 26: Medical Devices (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019 Table 27: Medical Devices (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 Table 28: Other End-Uses (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 29: Other End-Uses (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019 Table 30: Other End-Uses (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Clinical Trial Management Systems (CTMS) Market Share (in %) by Company: 2018 & 2025 Market Analytics Table 31: United States Clinical Trial Management Systems (CTMS) Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027 Table 32: Clinical Trial Management Systems (CTMS) Market in the United States by Type: A Historic Review in US$ Thousand for 2012-2019 Table 33: United States Clinical Trial Management Systems (CTMS) Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 34: United States Clinical Trial Management Systems (CTMS) Market Estimates and Projections in US$ Thousand by Delivery Mode: 2020 to 2027 Table 35: Clinical Trial Management Systems (CTMS) Market in the United States by Delivery Mode: A Historic Review in US$ Thousand for 2012-2019 Table 36: United States Clinical Trial Management Systems (CTMS) Market Share Breakdown by Delivery Mode: 2012 VS 2020 VS 2027 Table 37: United States Clinical Trial Management Systems (CTMS) Latent Demand Forecasts in US$ Thousand by End-Use: 2
to 2027 Table 38: Clinical Trial Management Systems (CTMS) Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012-2019 Table 39: Clinical Trial Management Systems (CTMS) Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027 CANADA Table 40: Canadian Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 41: Canadian Clinical Trial Management Systems (CTMS) Historic Market Review by Type in US$ Thousand: 2012-2019 Table 42: Clinical Trial Management Systems (CTMS) Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 Table 43: Canadian Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Delivery Mode: 2020 to 2027 Table 44: Canadian Clinical Trial Management Systems (CTMS) Historic Market Review by Delivery Mode in US$ Thousand: 2012-2019 Table 45: Clinical Trial Management Systems (CTMS) Market in Canada: Percentage Share Breakdown of Sales by Delivery Mode for 2012, 2020, and 2027 Table 46: Canadian Clinical Trial Management Systems (CTMS) Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 Table 47: Clinical Trial Management Systems (CTMS) Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019 Table 48: Canadian Clinical Trial Management Systems (CTMS) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 JAPAN Table 49: Japanese Market for Clinical Trial Management Systems (CTMS): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 50: Clinical Trial Management Systems (CTMS) Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 51: Japanese Clinical Trial Management Systems (CTMS) Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 52: Japanese Market for Clinical Trial Management Systems (CTMS): Annual Sales Estimates and Projections in US$ Thousand by Delivery Mode for the Period 2020-2027 Table 53: Clinical Trial Management Systems (CTMS) Market in Japan: Historic Sales Analysis in US$ Thousand by Delivery Mode for the Period 2012-2019 Table 54: Japanese Clinical Trial Management Systems (CTMS) Market Share Analysis by Delivery Mode: 2012 VS 2020 VS 2027 Table 55: Japanese Demand Estimates and Forecasts for Clinical Trial Management Systems (CTMS) in US$ Thousand by End-Use: 2020 to 2027 Table 56: Japanese Clinical Trial Management Systems (CTMS) Market in US$ Thousand by End-Use: 2012-2019 Table 57: Clinical Trial Management Systems (CTMS) Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027 CHINA Table 58: Chinese Clinical Trial Management Systems (CTMS) Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 59: Clinical Trial Management Systems (CTMS) Historic Market Analysis in China in US$ Thousand by Type: 2012-2019 Table 60: Chinese Clinical Trial Management Systems (CTMS) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 61: Chinese Clinical Trial Management Systems (CTMS) Market Growth Prospects in US$ Thousand by Delivery Mode for the Period 2020-2027 Table 62: Clinical Trial Management Systems (CTMS) Historic Market Analysis in China in US$ Thousand by Delivery Mode: 2012-2019 Table 63: Chinese Clinical Trial Management Systems (CTMS) Market by Delivery Mode: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 64: Chinese Demand for Clinical Trial Management Systems (CTMS) in US$ Thousand by End-Use: 2020 to 2027 Table 65: Clinical Trial Management Systems (CTMS) Market Review in China in US$ Thousand by End-Use: 2012-2019 Table 66: Chinese Clinical Trial Management Systems (CTMS) Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 EUROPE Market Facts & Figures European Clinical Trial Management Systems (CTMS) Market: Competitor Market Share Scenario (in %) for 2018 & 2025 Market Analytics Table 67: European Clinical Trial Management Systems (CTMS) Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 Table 68: Clinical Trial Management Systems (CTMS) Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 Table 69: European Clinical Trial Management Systems (CTMS) Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 70: European Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 71: Clinical Trial Management Systems (CTMS) Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 72: European Clinical Trial Management Systems (CTMS) Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 73: European Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Delivery Mode: 2020-2027 Table 74: Clinical Trial Management Systems (CTMS) Market in Europe in US$ Thousand by Delivery Mode: A Historic Review for the Period 2012-2019 Table 75: European Clinical Trial Management Systems (CTMS) Market Share Breakdown by Delivery Mode: 2012 VS 2020 VS 2027 Table 76: European Clinical Trial Management Systems (CTMS) Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 Table 77: Clinical Trial Management Systems (CTMS) Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019 Table 78: European Clinical Trial Management Systems (CTMS) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 FRANCE Table 79: Clinical Trial Management Systems (CTMS) Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 80: French Clinical Trial Management Systems (CTMS) Historic Market Scenario in US$ Thousand by Type: 2012-2019 Table 81: French Clinical Trial Management Systems (CTMS) Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 82: Clinical Trial Management Systems (CTMS) Market in France by Delivery Mode: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 83: French Clinical Trial Management Systems (CTMS) Historic Market Scenario in US$ Thousand by Delivery Mode: 2012-2019 Table 84: French Clinical Trial Management Systems (CTMS) Market Share Analysis by Delivery Mode: 2012 VS 2020 VS 2027 Table 85: Clinical Trial Management Systems (CTMS) Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027 Table 86: French Clinical Trial Management Systems (CTMS) Historic Market Review in US$ Thousand by End-Use: 2012-2019 Table 87: French Clinical Trial Management Systems (CTMS) Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 GERMANY Table 88: Clinical Trial Management Systems (CTMS) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 89: German Clinical Trial Management Systems (CTMS) Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 90: German Clinical Trial Management Systems (CTMS) Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 91: Clinical Trial Management Systems (CTMS) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Delivery Mode for the Period 2020-2027 Table 92: German Clinical Trial Management Systems (CTMS) Historic Market Analysis in US$ Thousand by Delivery Mode: 2012-2019 Table 93: German Clinical Trial Management Systems (CTMS) Market Share Breakdown by Delivery Mode: 2012 VS 2020 VS 2027 Table 94: Clinical Trial Management Systems (CTMS) Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027 Table 95: German Clinical Trial Management Systems (CTMS) Market in Retrospect in US$ Thousand by End-Use: 2012-2019 Table 96: Clinical Trial Management Systems (CTMS) Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027 ITALY Table 97: Italian Clinical Trial Management Systems (CTMS) Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 98: Clinical Trial Management Systems (CTMS) Historic Market Analysis in Italy in US$ Thousand by Type: 2012-2019 Table 99: Italian Clinical Trial Management Systems (CTMS) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 100: Italian Clinical Trial Management Systems (CTMS) Market Growth Prospects in US$ Thousand by Delivery Mode for the Period 2020-2027 Table 101: Clinical Trial Management Systems (CTMS) Historic Market Analysis in Italy in US$ Thousand by Delivery Mode: 2012-2019 Table 102: Italian Clinical Trial Management Systems (CTMS) Market by Delivery Mode: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 103: Italian Demand for Clinical Trial Management Systems (CTMS) in US$ Thousand by End-Use: 2020 to 2027 Table 104: Clinical Trial Management Systems (CTMS) Market Review in Italy in US$ Thousand by End-Use: 2012-2019 Table 105: Italian Clinical Trial Management Systems (CTMS) Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 UNITED KINGDOM Table 106: United Kingdom Market for Clinical Trial Management Systems (CTMS): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 107: Clinical Trial Management Systems (CTMS) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 108: United Kingdom Clinical Trial Management Systems (CTMS) Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 109: United Kingdom Market for Clinical Trial Management Systems (CTMS): Annual Sales Estimates and Projections in US$ Thousand by Delivery Mode for the Period 2020-2027 Table 110: Clinical Trial Management Systems (CTMS) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Delivery Mode for the Period 2012-2019 Table 111: United Kingdom Clinical Trial Management Systems (CTMS) Market Share Analysis by Delivery Mode: 2012 VS 2020 VS 2027 Table 112: United Kingdom Demand Estimates and Forecasts for Clinical Trial Management Systems (CTMS) in US$ Thousand by End-Use: 2020 to 2027 Table 113: United Kingdom Clinical Trial Management Systems (CTMS) Market in US$ Thousand by End-Use: 2012-2019 Table 114: Clinical Trial Management Systems (CTMS) Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027 REST OF EUROPE Table 115: Rest of Europe Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 116: Clinical Trial Management Systems (CTMS) Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 117: Rest of Europe Clinical Trial Management Systems (CTMS) Market Share Breakdown by Type: 2012 VS 2020 VS 2027 Table 118: Rest of Europe Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Delivery Mode: 2020-2027 Table 119: Clinical Trial Management Systems (CTMS) Market in Rest of Europe in US$ Thousand by Delivery Mode: A Historic Review for the Period 2012-2019 Table 120: Rest of Europe Clinical Trial Management Systems (CTMS) Market Share Breakdown by Delivery Mode: 2012 VS 2020 VS 2027 Table 121: Rest of Europe Clinical Trial Management Systems (CTMS) Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 Table 122: Clinical Trial Management Systems (CTMS) Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019 Table 123: Rest of Europe Clinical Trial Management Systems (CTMS) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 124: Clinical Trial Management Systems (CTMS) Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 125: Asia-Pacific Clinical Trial Management Systems (CTMS) Historic Market Scenario in US$ Thousand by Type: 2012-2019 Table 126: Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share Analysis by Type: 2012 VS 2020 VS 2027 Table 127: Clinical Trial Management Systems (CTMS) Market in Asia-Pacific by Delivery Mode: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 128: Asia-Pacific Clinical Trial Management Systems (CTMS) Historic Market Scenario in US$ Thousand by Delivery Mode: 2012-2019 Table 129: Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share Analysis by Delivery Mode: 2012 VS 2020 VS 2027 Table 130: Clinical Trial Management Systems (CTMS) Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027 Table 131: Asia-Pacific Clinical Trial Management Systems (CTMS) Historic Market Review in US$ Thousand by End-Use: 2012-2019 Table 132: Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share Analysis: A 17-Year Perspectiveby End-Use for 2012, 2020, and 2027 REST OF WORLD Table 133: Rest of World Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 134: Rest of World Clinical Trial Management Systems (CTMS) Historic Market Review by Type in US$ Thousand: 2012-2019 Table 135: Clinical Trial Management Systems (CTMS) Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 Table 136: Rest of World Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Delivery Mode: 2020 to 2027 Table 137: Rest of World Clinical Trial Management Systems (CTMS) Historic Market Review by Delivery Mode in US$ Thousand: 2012-2019 Table 138: Clinical Trial Management Systems (CTMS) Market in Rest of World: Percentage Share Breakdown of Sales by Delivery Mode for 2012, 2020, and 2027 Table 139: Rest of World Clinical Trial Management Systems (CTMS) Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 Table 140: Clinical Trial Management Systems (CTMS) Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019 Table 141: Rest of World Clinical Trial Management Systems (CTMS) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION

Total Companies Profiled: 62
Read the full report: https://www.reportlinker.com/p05336779/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________